- Report
- February 2026
- 329 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 561 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 196 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 202 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 232 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- May 2025
- 117 Pages
Global
From €4169EUR$4,750USD£3,627GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,779GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,779GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,779GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,779GBP
- Report
- August 2025
- 150 Pages
Global
From €3467EUR$3,950USD£3,017GBP
- Report
- February 2026
- 277 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,779GBP
- Report
- June 2025
- 400 Pages
Global
From €4344EUR$4,949USD£3,779GBP
- Report
- November 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- October 2025
- 160 Pages
Global
From €3467EUR$3,950USD£3,017GBP
- Report
- August 2025
- 150 Pages
Global
From €3467EUR$3,950USD£3,017GBP
- Report
- August 2025
- 150 Pages
Global
From €3467EUR$3,950USD£3,017GBP
- Report
- June 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- June 2025
Global
From €6583EUR$7,500USD£5,728GBP

The AIDS market within the context of Allergy and Immunology is focused on the development of treatments and therapies for HIV/AIDS. This includes the development of drugs to treat HIV infection, as well as vaccines and other therapies to prevent the spread of the virus. Additionally, research is being conducted to better understand the mechanisms of HIV infection and the development of new treatments.
The market is highly competitive, with many companies vying for a share of the market. Companies such as Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and ViiV Healthcare are all major players in the AIDS market. Other companies such as AbbVie, Janssen, and Pfizer are also involved in the development of treatments and therapies for HIV/AIDS. Show Less Read more